Use of dipeptidyl peptidase-4 inhibitors is associated with a lower risk of rheumatoid arthritis in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of cohort studies
Publication date: Available online 8 January 2021Source: Diabetes & Metabolic Syndrome: Clinical Research & ReviewsAuthor(s): Nipith Charoenngam, Thanitsara Rittiphairoj, Ben Ponvilawan, Patompong Ungprasert
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
More News: Arthritis | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Metabolic Syndrome | Rheumatoid Arthritis | Rheumatology | Study